•  
  •  
  •  
  •  

2026-05-14 01:47:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Cybertech Systems and Software Ltd Q4 FY2025-26 consolidated net profit at Rs. 7.06 crores
  • JSW Dulux Ltd Q4 FY2026 consolidated PAT rises to Rs. 125.7 crores
  • LIC Housing Finance Ltd Q4 FY2026 consolidated PAT up at Rs. 1492.54 crores
  • Nitco Ltd Q4 FY26 consolidated loss at Rs. 7.78 crore
  • Chemfab Alkalis Ltd Q4FY26 consolidated profit at Rs. 48.46 lakhs

Keywords Selected:  INE068V01023

Stock Report

  • Gland Pharma Ltd receives tentative approval from USFDA
  • Gland Pharma Limited announces resignation of CEO
  • Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Gland Pharma Ltd receives GMP compliance from Danish Medicines Agency
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Gland Pharma Receives Approval for Angiotensin II Acetate Injection
  • Gland Pharma receives approval from USFDA for Latanoprostene Bunod Opthalmic Solution
  • Gland Pharma receives approval for Acetaminophen Injection
  • USFDA issues Form 483 with 3 observations to Gland Pharma's Sterile APIs unit
  • ANSM Inspection at Cenexi's Fontenay Manufacturing Facility
  • Gland Pharma receives approval for Phytonadione Injection Emulsion
  • Gland Pharma receives approval for Latanoprost Opthalmic Solution, 0.005% (2.5 mL Fill)
  • Surprise USFDA inspection at Gland Pharma Limited's Dundigal Facility
  • Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution
  • Srinivas Sadu appointed as Executive Chairman and CEO of Gland Pharma Ltd
  • Gland Pharma receives approval for Edaravone Injection
  • Gland Pharma receives approval for Plerixafor for Injection
  • Gland Pharma receives approval for Cetrorelix Acetate for Injection
  • Gland Pharma receives approval for Eribulin Mesylate Injection
  • Gland Pharma Ltd receives EIR from USFDA for Pashamylaram Facility at Hyderabad
  • Gland Pharma Limited updates on USFDA Pre-Market Inspection at Pashamylaram Facility

Latest Post

  • Cybertech Systems and Software Ltd Q4 FY2025-26 consolidated net profit at Rs. 7.06 crores
  • JSW Dulux Ltd Q4 FY2026 consolidated PAT rises to Rs. 125.7 crores
  • LIC Housing Finance Ltd Q4 FY2026 consolidated PAT up at Rs. 1492.54 crores
  • Nitco Ltd Q4 FY26 consolidated loss at Rs. 7.78 crore
  • Chemfab Alkalis Ltd Q4FY26 consolidated profit at Rs. 48.46 lakhs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025